Cascadian Therapeutics, Inc. — Net Income by Fiscal Year
9 fiscal years, as filed with the SEC; every row links its evidence fact.
Cite as: FACTANKER, https://factanker.com/entity/553a935e-be7d-40dc-a9fd-677038d127a0/serie/net-income
| Fiscal year | Net Income | Period | Evidence |
|---|---|---|---|
| FY 2017 | $-56.9M | 2017-01-01 – 2017-12-31 | evidence 0001193125-18-075320 |
| FY 2016 | $-57.7M | 2016-01-01 – 2016-12-31 | evidence 0001193125-17-076986 |
| FY 2015 | $-32.6M | 2015-01-01 – 2015-12-31 | evidence 0001193125-16-503582 |
| FY 2014 | $-9.6M | 2014-01-01 – 2014-12-31 | evidence 0001193125-15-182133 |
| FY 2013 | $-38.8M | 2013-01-01 – 2013-12-31 | evidence 0001193125-14-097925 |
| FY 2012 | $-3.4M | 2012-01-01 – 2012-12-31 | evidence 0001193125-13-107372 |
| FY 2011 | $-42.7M | 2011-01-01 – 2011-12-31 | evidence 0001193125-12-107156 |
| FY 2010 | $-15.6M | 2010-01-01 – 2010-12-31 | evidence 0001193125-12-107156 |
| FY 2009 | $-17.2M | 2009-01-01 – 2009-12-31 | evidence 0001193125-12-107156 |
Methodology & sources
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
One value per fiscal year (period > 300 days, latest period end per year); fiscal years ending Jun–Dec count toward the ending calendar year, Jan–May toward the prior year. Values as filed (XBRL concept per evidence fact). Source: SEC EDGAR (public domain).
Cascadian Therapeutics, Inc. — all facts · Revenue · Operating Income